Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3696861 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL11969993 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL29152258 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL4275167 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL952696 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL934045 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL754660 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL163408 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL4191445 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL11653301 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260123372-A1 | MANUFACTURING SEMICONDUCTOR DEVICE USING SELECTIVE DIELECTRIC ON DIELECTRIC (DOD) DEPOSITION PROCESS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-04-30 | — | — | US | claimed |
| US-12518966-B2 | Selective plasma enhanced atomic layer deposition | VERSUM MATERIALS US, LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-20250379101-A1 | SURFACE PASSIVATION FOR ACHIEVING CONTROLLABLE QUEUE TIME FOR POST-PLANARIZATION PROCESS | TOKYO ELECTRON LTD (JP) | 2025-12-11 | — | — | US | claimed |
| US-20250332595-A1 | PARTICLE SORTING SYSTEMS AND METHODS | ORCA BIOSYSTEMS, INC. (US) | 2025-10-30 | — | — | US | claimed |
| US-20250314585-A1 | LOCALISED SURFACE PLASMONIC SENSING | THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2025-10-09 | — | — | US | claimed |
| US-12409490-B2 | Light-mediated manipulation of droplets stabilized by fluorinated nanoparticles with photothermal effect | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-09-09 | — | — | US | claimed |
| US-12406887-B2 | Selective film formation using a self-assembled monolayer | TOKYO ELECTRON LIMITED (JP) | 2025-09-02 | — | — | US | claimed |
| CN-120137515-A | High-strength antifouling porcelain insulator and preparation method thereof | 江西利红电瓷制造有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120136410-A | Production process of wear-resistant super-hydrophobic high-transmittance embossed glass for solar cells | 上海钙晶科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120118592-A | Self-healing super-hydrophobic corrosion-resistant composite coating and preparation method and application thereof | 长安大学 | 2025-06-10 | — | — | CN | claimed |
| US-20070105396-A1 | High resolution structures defined by brush painting fluid onto surface energy patterned substrates | SEIKO EPSON CORPORATION (JP) | 2007-05-10 | — | — | US | claimed |
| WO-2006113621-A2 | FORMULATIONS FOR CLEANING ION-IMPLANTED PHOTORESIST LAYERS FROM MICROELECTRONIC DEVICES | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2006-10-26 | — | — | WO | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1330477-A2 | RHEOLOGY MODIFYING COPOLYMER COMPOSITION | Noveon IP Holdings Corp. (US) | 2003-07-30 | — | — | EP | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| US-6488357-B2 | Corrision resistant hydrophobic liquid level control plate for printhead of ink jet printer and process | XEROX CORPORATION | 2002-12-03 | — | — | US | claimed |
| US-6433061-B1 | CROSSLINKED COPOLYMER OF UNSATURATED CARBOXYLIC ACID, HYDROPHOBIC MONOMER, AND CHAIN TRANSFER AGENT; INCREASES VISCOSITY IN SALT-CONTAINING SYSTEMS; FOR USE IN SHAMPOOS, CLEANERS, AND DRUG DELIVERY SYSTEMS | NOVEON IP HOLDINGS CORP. | 2002-08-13 | — | — | US | claimed |
| US-20020097297-A1 | Corrision resistant hydrophobic liquid level control plate for printhead of ink jet printer and process | XEROX CORPORATION | 2002-07-25 | — | — | US | claimed |
| WO-2002034793-A2 | RHEOLOGY MODIFYING COPOLYMER COMPOSITION | NOVEON IP HOLDINGS CORP. (US) | 2002-05-02 | — | — | WO | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123372-A1 | MANUFACTURING SEMICONDUCTOR DEVICE USING SELECTIVE DIELECTRIC ON DIELECTRIC (DOD) DEPOSITION PROCESS | PDK1, HPD, HAO2 | LMNA 4754/4885THRB 3793/4885CA2 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.